Member Info for WeTookPelham

"...isn't lots of potential news/data due? And in the near horizon?"
Genuine question...have I gotten this incorrect?

Please stop stirring AB.

Who accused violindog of being someone else? I said reminiscent.

P.s. I agree, we are a perfect fit for Biontech.
With the existing relationship you'd think there was something deeper going on?

It was the "....with no news from SCLP on the near horizon" comment, isn't lots of potential news/data due? And in the near horizon?

And the connected RE "holding 13p" comment.
Again all IMO.
LTH fatigue is a real phenomenon though I agree.

Nobody knows exactly when news will land, that's the whole point isn't it, we wait for game changing news.
That's one of the reasons I asked about results, to get some idea of "potential" dates.

@violindog, not sure if it's just LTH fatigue, but your posting style is changing and becoming reminiscent of past bearish posters...all IMO.

"....with no news from SCLP on the near horizon"
???
Come again?

... could someone kindly just briefly re-summarise when potential data points for the various trials could (hopefully) be released by?

?
Show's tiny trades can make a difference on low volume days?

@Dalestar
This rang a bell, and it does seem so:
https://www.jobs.ac.uk/job/CBY342?
I'm not sure if it's this person as I don't have a linkedin account to see their full profile:
https://uk.linkedin.com/in/abdullah-al-omari-6a5429128

@burble/other science bods - Thoughts on the more senior 2x Research Scientist roles? (rather than the 1x research technician role originally mentioned)

https://www.jobs.ac.uk/job/CQV176/research-technician-antibody-discovery
https://www.jobs.ac.uk/job/CQV177/research-scientist-antibody-discovery-two-posts

2 X role:
Main duties and responsibilities:

Design and execute experiments to generate new GlymAb using standard hybridoma as well B cell repertoire mining technologies
Validation of mAb target binding (ELISA and Biacore) and target distribution (cell-based and immunohistochemical analyses)
Analyses of in vitro and in vivo mAb-mediated tumour killing through a range of mAb formats
Data analyses as well as recording and presenting results
Frequent review of relevant literature to contribute to project progression
Personal specification:

Laboratory-focused, analytical mindset, results-driven, reliable under pressure, enthusiastic, collaborative, time management skills, and problem-solving skills

Edit...advert for 2 X posts seems much more specialised and senior, i.e. requires a PhD, so almost definitely not the same as the original one I mentioned:

"Specific requirements:

Essential

PhD Degree in biochemistry or immunology-related discipline
Proven experience in the production and characterisation of mAbs
Proficient in sterile cell culture, including primary human/mouse immune cells
Experience in multicolour flow cytometry
Excellent record keeping and data analyses skills, attention to detail and accuracy
Computer literate with proficiency in a wide range of data analysis packages
Flexibility in working independently and as part of a team, as well as meeting tight deadlines
Desirable

Antibody discovery using B-cell technologies, including B cell sequencing and bioinformatic analyses
Experience in the use of Biacore (or similar) to analyse mAb target binding
Cell sorting experience
Keen interest in learning new techniques
Training of less experienced team members"

But that's 3 X new roles in total then.

Actually, the advert where it says "two posts", I can't work out if the job spec is different or just in more detail??? One for the science bods?
But either way they aren't the same job specs verbatim.

https://www.jobs.ac.uk/job/CQV176/research-technician-antibody-discovery

https://www.jobs.ac.uk/job/CQV177/research-scientist-antibody-discovery-two-posts

Not sure if some glitch with the posting but perhaps there are two positions for the role?
https://www.jobs.ac.uk/search/employer/scancell-ltd

@Burble - my pleasure.

However...I was both enthused and somewhat deflated by your interpretation of the role, I guess I am now in the camp of "Please Scancell, sign a deal now, any deal! I've been here too long!".
I understand the need to increase the IP and "maximise shareholder value", but at some point shareholder value has to materialise, I, and I think many others, just want the latter now.
I appreciate we might be very close/closer than we've ever been and the IP is now very substantial but Scancell should (and can) do deals whilst still concurrently developing the science...IMO.

You'd think the weak pound would help encourage US pharma looking at UK bios?

https://www.jobs.ac.uk/job/CQV176/research-technician-antibody-discovery

Scancell Ltd is an innovative biotech company with research facilities based at the University of Nottingham, as well as offices and Development laboratories at the Oxford Science Park. Scancell is currently conducting a Phase 2 trial of its ImmunoBody® vaccine and a first-in-human Phase 1/2 study of its Moditope® vaccine in patients with melanoma and advanced solid tumours, respectively. Additionally, Scancell is expanding its Glymab and Avidimab platforms.

This underpinning role within Scancell’s Antibody team will support the dynamic Antibody discovery team, in order to progress our portfolio of cancer-targeting antibodies (Glymab) towards the clinic.

This lab-based role will have responsibility for the day-to-day running of the laboratory by providing technical support for the experimental work. The post-holder will report to the Senior Scientist and will work closely with other team members.

Main duties and responsibility:

Maintaining cell cultures, isolation of primary murine and human immune cells and cryopreservation of relevant cells
Regular mycoplasma testing
Perform functional immune assays, including ELISA and flow cytometry
Prepare and aliquot reagent solutions and buffers
Management of reagent stocks, database recording and ordering
Contribute to or review laboratory documentation, maintain accurate laboratory book

...15p paid again (albeit only a small amount), it's been a while.

https://www.wsj.com/articles/can-we-develop-a-covid-19-vaccine-that-lasts-11655478373

Can We Develop a Covid-19 Vaccine That Lasts?

"New variants have weakened the protection of the current shots, which require unpopular boosters. Scientists and the White House are exploring options for more durable protection, but success could take years."

Years? Depends where you're looking I guess.